Shuangshuang Zhao

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Risk Factors and Preoperative Prediction Model for Endometrial Lesions in Postmenopausal Patients with Benign Ovarian Tumors: A Retrospective Single-Center Study.

Risk Factors and Preoperative Prediction Model for Endometrial Lesions in Postmenopausal Patients with Benign Ovarian Tumors: A Retrospective Single-Center Study.

Journal: International journal of women's health

Published: November 03, 2025

Rab35 drives the malignant progression of endometrial carcinoma by regulating the nuclear translocation of β-catenin.

Rab35 drives the malignant progression of endometrial carcinoma by regulating the nuclear translocation of β-catenin.

Journal: Experimental cell research

Published: October 15, 2025

AQB improves carboplatin sensitivity in endometrial cancer through dual DNA repair modulation: suppression of the p21-E2F1-RAD51 and ATF3-HDAC1-BRCA1 signaling.

AQB improves carboplatin sensitivity in endometrial cancer through dual DNA repair modulation: suppression of the p21-E2F1-RAD51 and ATF3-HDAC1-BRCA1 signaling.

Journal: Cell death & disease

Published: February 22, 2025

The Value of Integrating Hormone Receptors into Immunohistochemistry-Based Simplified Molecular Classification in Endometrial Cancer.

The Value of Integrating Hormone Receptors into Immunohistochemistry-Based Simplified Molecular Classification in Endometrial Cancer.

Journal: Cancer management and research

Published: January 21, 2025

PFKFB4 promotes endometrial cancer by regulating glycolysis through SRC‑3 phosphorylation.

PFKFB4 promotes endometrial cancer by regulating glycolysis through SRC‑3 phosphorylation.

Journal: Oncology reports

Published: December 04, 2024

Interleukin-22 promotes endometrial carcinoma cell proliferation and cycle progression via ERK1/2 and p38 activation.

Interleukin-22 promotes endometrial carcinoma cell proliferation and cycle progression via ERK1/2 and p38 activation.

Journal: Molecular and cellular biochemistry

Published: August 06, 2024

Author Correction: A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma.

Author Correction: A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma.

Journal: Scientific reports

Published: April 17, 2024

A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma.

A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma.

Journal: Scientific reports

Published: November 22, 2023

Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta-analysis.

Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta-analysis.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: October 17, 2023

Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer.

Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer.

Journal: Cancer letters

Published: July 12, 2023

CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis.

CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis.

Journal: Hereditas

Published: December 19, 2022

Endometrial cancer in Lynch syndrome.

Endometrial cancer in Lynch syndrome.

Journal: International journal of cancer

Published: May 19, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026